- Home
- RNA vs ASB Comparison
RNA vs ASB Comparison
Compare RNA & ASB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNA
- ASB
- Stock Information
- Founded
- RNA 2012
- ASB 1861
- Country
- RNA United States
- ASB United States
- Employees
- RNA N/A
- ASB N/A
- Industry
- RNA Biotechnology: Pharmaceutical Preparations
- ASB Major Banks
- Sector
- RNA Health Care
- ASB Finance
- Exchange
- RNA Nasdaq
- ASB Nasdaq
- Market Cap
- RNA 4.0B
- ASB 4.1B
- IPO Year
- RNA 2020
- ASB N/A
- Fundamental
- Price
- RNA $69.83
- ASB $25.43
- Analyst Decision
- RNA Buy
- ASB Hold
- Analyst Count
- RNA 20
- ASB 12
- Target Price
- RNA $69.26
- ASB $28.00
- AVG Volume (30 Days)
- RNA 9.8M
- ASB 1.7M
- Earning Date
- RNA 11-07-2025
- ASB 10-23-2025
- Dividend Yield
- RNA N/A
- ASB 3.75%
- EPS Growth
- RNA N/A
- ASB N/A
- EPS
- RNA N/A
- ASB 0.98
- Revenue
- RNA $10,729,000.00
- ASB $1,097,713,000.00
- Revenue This Year
- RNA N/A
- ASB $57.53
- Revenue Next Year
- RNA $108.97
- ASB $5.33
- P/E Ratio
- RNA N/A
- ASB $26.06
- Revenue Growth
- RNA 1.23
- ASB 8.93
- 52 Week Low
- RNA $21.51
- ASB $18.32
- 52 Week High
- RNA $70.51
- ASB $28.18
- Technical
- Relative Strength Index (RSI)
- RNA 79.30
- ASB 51.35
- Support Level
- RNA $69.50
- ASB $24.33
- Resistance Level
- RNA $69.86
- ASB $25.60
- Average True Range (ATR)
- RNA 0.88
- ASB 0.57
- MACD
- RNA 0.81
- ASB 0.05
- Stochastic Oscillator
- RNA 91.19
- ASB 66.77
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.
About ASB Associated Banc-Corp
Associated Banc-Corp is a bank holding company. The company through its subsidiaries provides a broad array of banking and nonbanking products and services to individuals and businesses. The company operates in three reportable segments; Corporate and Commercial Specialty; Community, Consumer, and Business; and Risk Management and Shared Services. The majority of its revenue is derived from the Corporate and Commercial Specialty and Community, Consumer, and Business segments.